Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc took a tumble today and lost -€0.180 (-3.880%).
So far the community has only identified positive things for Champions Oncology Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | -3.880% | -13.398% | -15.048% | -15.048% | -23.103% | -23.761% | -48.439% |
| Evolus Inc | -1.260% | -3.871% | -15.000% | -34.208% | -7.046% | -44.330% | -42.757% |
| Heron Therapeutics Inc. | 0.230% | 2.964% | 15.931% | -70.432% | -61.329% | -70.694% | -95.846% |
| Rhythm Pharmaceuticals | 0.000% | -5.000% | -11.856% | 14.765% | -8.556% | 437.736% | 493.750% |
News
Champions Oncology Q4 Earnings Call Highlights
Key Points
- Interested in Champions Oncology, Inc.? Here are five stocks we like better.
- Record fiscal 2026 performance: Revenue reached $59.4 million, up from the prior year, and adjusted
West Pharmaceutical Services Q2 Earnings Call Highlights
Key Points
- Interested in West Pharmaceutical Services, Inc.? Here are five stocks we like better.
- West Pharmaceutical Services beat second-quarter expectations, with revenue up 13% organically
KinderCare Learning Companies Q1 Earnings Call Highlights
KinderCare Learning Companies (NYSE:KLC) reported modest first-quarter revenue growth while management said lower enrollment in its early childhood education centers continued to pressure